Sponsor Pipeline

Fundación GECP Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
15
Active Trials
7
Recruiting
2
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
10
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06431633 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer… Lung Diseases Recruiting
NCT04564157 New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy Non-Small Cell Lung Cancer Active, Not Recruiting
Phase 2
NCT06917573 PALACE: Cemiplimab Trial According to ctDNA Levels Non Small Cell Lung Cancer Metastatic Recruiting
NCT07153445 Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment… Non Small Cell Lung Cancer Recruiting
NCT05398094 Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and… Non-small Cell Lung Cancer Stage III Recruiting
NCT07242547 Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage… Limited-stage Small-cell Lung Cancer Recruiting
NCT04223596 Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients Lung Cancer Active, Not Recruiting
NCT03838159 NADIM II: Neo-Adjuvant Immunotherapy Non Small Cell Lung Cancer Active, Not Recruiting
NCT05384015 Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line… Small Cell Lung Cancer Extensive Stage Active, Not Recruiting
NCT05012254 Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With… Non Small Cell Lung Cancer Active, Not Recruiting
NCT05684276 DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors NSCLC Active, Not Recruiting
NCT07247786 Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage… Non Small Cell Lung Cancer Not Yet Recruiting
Not specified
NCT06634199 Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III… Non-small Cell Lung Cancer Stage III Recruiting
NCT05167487 Pathological Response After Neoadjuvant Treatment on NSCLC Stage IIIA Non-small Cell Lung Cancer Recruiting
NCT05382052 Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With… Non Small Cell Lung Cancer Stage III Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (13) Lung Cancer (13) Small Cell Lung Cancer (1)
Get alerts when Fundación GECP's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free